Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil Recalls Cut J&J's Profits, Draw U.S. Attorney's Subpoena

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm will not resume selling the OTC products that were the subject of the recall until 2011.
Advertisement

Related Content

Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
J&J Pharma Hit By EU Price Cuts, Weaker Euro
J&J Pharma Hit By EU Price Cuts, Weaker Euro
J&J Pharma Hit By EU Price Cuts, Weaker Euro
Congress Hopes To Land J&J Chief Weldon For Second Recall Inquiry

Topics

Advertisement
UsernamePublicRestriction

Register

PS070931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel